Other specified carcinomas of liver
- C22.7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C22.7 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C22.7 – other international versions of ICD-10 C22.7 may differ.
The following code(s) above C22.7 contain annotation back-references
that may be applicable to C22.7:
- C00-D49 Neoplasms
- C15-C26 Malignant neoplasms of digestive organs
- C22 Malignant neoplasm of liver and intrahepatic bile ducts
ICD-10-CM C22.7 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 435 Malignancy of hepatobiliary system or pancreas with mcc
- 436 Malignancy of hepatobiliary system or pancreas with cc
- 437 Malignancy of hepatobiliary system or pancreas without cc/mcc
Convert C22.7 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Diagnosis Index entries containing back-references to C22.7:
- Carcinoma (malignant) – see also Neoplasm, by site, malignant
- embryonal
- liver C22.7
- liver NEC C22.7
- embryonal
- Teratocarcinoma – see also Neoplasm, malignant, by site
- liver C22.7
- Teratoma (solid) – see also Neoplasm, uncertain behavior, by site
- embryonal – see also Neoplasm, malignant, by site
- liver C22.7
- liver C22.7
- embryonal – see also Neoplasm, malignant, by site
- Tumor – see also Neoplasm, unspecified behavior, by site
- embryonal (mixed) – see also Neoplasm, uncertain behavior, by site
- liver C22.7
- embryonal (mixed) – see also Neoplasm, uncertain behavior, by site